Select Publications
Journal articles
2024, 'A foundation model for clinical-grade computational pathology and rare cancers detection', Nature Medicine, 30, pp. 2924 - 2935, http://dx.doi.org/10.1038/s41591-024-03141-0
,2024, 'Development and Validation of a HER2-Low Focused Immunohistochemical Scoring System With High-Interobserver Concordance: The Australian HER2-Low Breast Cancer Concordance Study', Modern Pathology, 37, http://dx.doi.org/10.1016/j.modpat.2024.100535
,2024, 'Artificial Intelligence Helps Pathologists Increase Diagnostic Accuracy and Efficiency in the Detection of Breast Cancer Lymph Node Metastases', American Journal of Surgical Pathology, 48, pp. 846 - 854, http://dx.doi.org/10.1097/PAS.0000000000002248
,2024, 'BioFusionNet: Deep Learning-Based Survival Risk Stratification in ER+ Breast Cancer Through Multifeature and Multimodal Data Fusion', IEEE Journal of Biomedical and Health Informatics, 28, pp. 5290 - 5302, http://dx.doi.org/10.1109/JBHI.2024.3418341
,2024, 'Generalized deep learning for histopathology image classification using supervised contrastive learning', Journal of Advanced Research, http://dx.doi.org/10.1016/j.jare.2024.11.013
,2023, 'Breast cancer histopathology image-based gene expression prediction using spatial transcriptomics data and deep learning', Scientific Reports, 13, pp. 13604, http://dx.doi.org/10.1038/s41598-023-40219-0
,2023, 'MCP-1 expression in breast cancer and its association with distant relapse', Cancer Medicine, 12, pp. 16221 - 16230, http://dx.doi.org/10.1002/cam4.6284
,2023, 'hist2RNA: An Efficient Deep Learning Architecture to Predict Gene Expression from Breast Cancer Histopathology Images', Cancers, 15, pp. 2569, http://dx.doi.org/10.3390/cancers15092569
,2023, 'Abstract PD9-01: Stromal mediators of lymphocyte exclusion and dysfunction in triple negative breast cancer', Cancer Research, 83, http://dx.doi.org/10.1158/1538-7445.sabcs22-pd9-01
,2022, 'Survival prediction in triple negative breast cancer using multiple instance learning of histopathological images', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-18647-1
,2022, 'Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low-grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR)', Histopathology, 81, pp. 467 - 476, http://dx.doi.org/10.1111/his.14725
,2022, 'ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo', Advanced Science, 9, http://dx.doi.org/10.1002/advs.202103332
,2022, 'Fecal DNA Virome Is Associated with the Development of Colorectal Neoplasia in a Murine Model of Colorectal Cancer', Pathogens, 11, http://dx.doi.org/10.3390/pathogens11040457
,2022, '93P An AI-driven computational biomarker from H&E slides recovers cases with low levels of HER2 from immunohistochemically HER2-negative breast cancers', Annals of Oncology, 33, pp. S581 - S581, http://dx.doi.org/10.1016/j.annonc.2022.07.125
,2021, 'Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis', Genome Medicine, 13, http://dx.doi.org/10.1186/s13073-021-00885-z
,2021, 'Multiplexed immunofluorescence identifies high stromal CD68+PD-L1+ macrophages as a predictor of improved survival in triple negative breast cancer', Scientific Reports, 11, http://dx.doi.org/10.1038/s41598-021-01116-6
,2021, 'The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group', npj Breast Cancer, 7, http://dx.doi.org/10.1038/s41523-021-00346-1
,2021, 'A single-cell and spatially resolved atlas of human breast cancers', Nature Genetics, 53, pp. 1334 - 1347, http://dx.doi.org/10.1038/s41588-021-00911-1
,2021, 'SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma but Overall Low Percentage Agreement with Other PD-L1 Clones SP263 and 22C3', American Journal of Surgical Pathology, 45, pp. 1108 - 1117, http://dx.doi.org/10.1097/PAS.0000000000001701
,2020, 'Tumour stroma ratio assessment using digital image analysis predicts survival in triple negative and luminal breast cancer', Cancers, 12, pp. 1 - 14, http://dx.doi.org/10.3390/cancers12123749
,2020, 'Tils immunophenotype in breast cancer predicts local failure and overall survival: Analysis in a large radiotherapy trial with long-term follow-up', Cancers, 12, pp. 1 - 15, http://dx.doi.org/10.3390/cancers12092365
,2020, 'Id Proteins Promote a Cancer Stem Cell Phenotype in Mouse Models of Triple Negative Breast Cancer via Negative Regulation of Robo1', Frontiers in Cell and Developmental Biology, 8, http://dx.doi.org/10.3389/fcell.2020.00552
,2020, 'Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis', bioRxiv, http://dx.doi.org/10.1101/2020.06.04.135277
,2020, 'Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients', Histopathology, 76, pp. 976 - 987, http://dx.doi.org/10.1111/his.14081
,2019, 'An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis', Nature Communications, 10, http://dx.doi.org/10.1038/s41467-019-10681-4
,2019, 'A case of amoebic colitis following remote historical exposure', ANZ Journal of Surgery, 89, pp. E222 - E223, http://dx.doi.org/10.1111/ans.14278
,2018, 'MASTL overexpression promotes chromosome instability and metastasis in breast cancer', Oncogene, 37, pp. 4518 - 4533, http://dx.doi.org/10.1038/s41388-018-0295-z
,2018, 'The magnitude of androgen receptor positivity in breast cancer is critical for reliable prediction of disease outcome', Clinical Cancer Research, 24, pp. 2328 - 2341, http://dx.doi.org/10.1158/1078-0432.CCR-17-1199
,2018, 'miR-139-5p modulates radiotherapy resistance in breast cancer by repressing multiple gene networks of DNA repair and ROS defense', Cancer Research, 78, pp. 501 - 515, http://dx.doi.org/10.1158/0008-5472.CAN-16-3105
,2017, 'Andy's Algorithms: New automated digital image analysis pipelines for FIJI', Scientific Reports, 7, http://dx.doi.org/10.1038/s41598-017-15885-6
,2017, 'Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer', Modern Pathology, 30, pp. 952 - 963, http://dx.doi.org/10.1038/modpathol.2017.21
,2017, 'LRH-1 expression patterns in breast cancer tissues are associated with tumour aggressiveness', Oncotarget, 8, pp. 83626 - 83636, http://dx.doi.org/10.18632/oncotarget.18886
,2016, 'MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib', Breast Cancer Research, 18, http://dx.doi.org/10.1186/s13058-016-0781-6
,2015, 'ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells', PLoS Biology, 13, http://dx.doi.org/10.1371/journal.pbio.1002330
,2015, 'MicroRNA-related DNA repair/cell-cycle genes independently associated with relapse after radiation therapy for early breast cancer', International Journal of Radiation Oncology Biology Physics, 93, pp. 1104 - 1114, http://dx.doi.org/10.1016/j.ijrobp.2015.08.046
,2015, 'Proteomic analysis of urine to identify breast cancer biomarker candidates using a label-free LC-MS/MS approach', PLoS ONE, 10, pp. e0141876, http://dx.doi.org/10.1371/journal.pone.0141876
,2015, 'Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumour', BMC Cancer, 15, http://dx.doi.org/10.1186/s12885-015-1676-0
,2015, 'DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer', Nature Communications, 6, http://dx.doi.org/10.1038/ncomms8758
,2015, 'ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype', NATURE COMMUNICATIONS, 6, http://dx.doi.org/10.1038/ncomms7548
,2015, 'ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype', Nature Communications, 6, http://dx.doi.org/10.1038/ncomms7548
,2014, 'Deletion of the antiphospholipid syndrome autoantigen β
2014, 'Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features', Breast cancer research : BCR, 16, pp. 423, http://dx.doi.org/10.1186/s13058-014-0423-9
,2014, 'MicroRNA regulation of radiotherapy sensitivity and resistance in breast cancer', INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 34, pp. S12 - S12, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000341276000031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Proteomics for breast cancer urine biomarkers', , 63, pp. 123 - 167, http://dx.doi.org/10.1016/B978-0-12-800094-6.00004-2
,2014, 'Candidate methylation profiling of ductal carcinoma in situ and its relationship to phenotype', Pathology, 46, pp. S76 - S76, http://dx.doi.org/10.1097/01.pat.0000443597.70603.41
,2013, 'Global characterization of signalling networks associated with tamoxifen resistance in breast cancer', FEBS Journal, 280, pp. 5237 - 5257, http://dx.doi.org/10.1111/febs.12441
,2013, 'β-catenin signaling is a critical event in ErbB2-mediated mammary tumor progression', Cancer Research, 73, pp. 4474 - 4487, http://dx.doi.org/10.1158/0008-5472.CAN-12-3925
,2013, 'The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial', Breast Cancer Research and Treatment, 139, pp. 115 - 123, http://dx.doi.org/10.1007/s10549-013-2508-z
,2013, 'Therapeutic targets in triple negative breast cancer', Journal of Clinical Pathology, 66, pp. 530 - 542, http://dx.doi.org/10.1136/jclinpath-2012-201361
,2012, 'Intrinsic subtype and its clinical significance in early node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy.', Journal of Clinical Oncology, 30, pp. 504 - 504, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.504
,